John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCT
2176
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $168K | ﹤0.01% |
7,547
-2,004
| -21% | -$44.7K |
|
2177
Zedge
ZDGE
$37.8M
| $167K | ﹤0.01% |
57,860
-10,892
| -16% | -$53.8K |
|
|
SREV
2178
DELISTED
ServiceSource International, Inc.
SREV
| $166K | ﹤0.01% |
113,021
+45,673
| +68% | +$60.8K |
|
|
HNGR
2179
DELISTED
Hanger Inc.
HNGR
| $164K | ﹤0.01% |
+11,461
| New | +$186K |
|
|
EPIX
2180
DELISTED
ESSA Pharma
EPIX
| $162K | ﹤0.01% |
51,456
-66,984
| -57% | -$374K |
|
2181
NSTS Bancorp
NSTS
$68.8M
| $161K | ﹤0.01% |
14,402
-28,090
| -66% | -$323K |
|
2182
Tiptree Inc
TIPT
$690M
| $161K | ﹤0.01% |
+15,158
| New | +$170K |
|
2183
Spyre Therapeutics
SYRE
$9.4B
| $160K | ﹤0.01% |
12,634
+3,970
| +46% | +$139K |
|
|
CWBR
2184
DELISTED
CohBar, Inc. Common Stock
CWBR
| $160K | ﹤0.01% |
28,194
-8,847
| -24% | -$59.2K |
|
2185
Forte Biosciences
FBRX
$1.63B
| $159K | ﹤0.01% |
4,892
-4,564
| -48% | -$145K |
|
2186
Viemed Healthcare
VMD
$346M
| $158K | ﹤0.01% |
29,308
+9,008
| +44% | +$48.6K |
|
|
PLM
2187
DELISTED
PolyMet Mining Corp.
PLM
| $158K | ﹤0.01% |
57,491
-60,849
| -51% | -$188K |
|
|
EEX
2188
DELISTED
Emerald Holding
EEX
| $157K | ﹤0.01% |
+38,570
| New | +$124K |
|
2189
EVI Industries
EVI
$190M
| $157K | ﹤0.01% |
+15,736
| New | +$209K |
|
2190
Protara Therapeutics
TARA
$229M
| $157K | ﹤0.01% |
53,548
-35,231
| -40% | -$129K |
|
|
SLI
2191
Standard Lithium
SLI
$600M
| $156K | ﹤0.01% |
+36,700
| New | +$217K |
|
2192
TMC The Metals Company
TMC
$2.09B
| $153K | ﹤0.01% |
+148,160
| New | +$229K |
|
|
LITS
2193
Lite Strategy Inc
LITS
$35M
| $152K | ﹤0.01% |
12,598
-24,874
| -66% | -$271K |
|
2194
Comscore
SCOR
$73.6M
| $150K | ﹤0.01% |
3,640
+255
| +8% | +$10.6K |
|
|
ADTH
2195
DELISTED
AdTheorent Holding Co
ADTH
| $149K | ﹤0.01% |
+48,229
| New | +$362K |
|
|
MACK
2196
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $148K | ﹤0.01% |
24,919
-5,820
| -19% | -$32.8K |
|
2197
Playtika
PLTK
$923M
| $146K | ﹤0.01% |
+11,000
| New | +$171K |
|
|
IVAC
2198
DELISTED
Intevac Inc
IVAC
| $146K | ﹤0.01% |
30,095
+10,094
| +50% | +$51.4K |
|
2199
Enliven Therapeutics
ELVN
$4.48B
| $145K | ﹤0.01% |
29,784
-31,252
| -51% | -$153K |
|
|
CMRX
2200
DELISTED
Chimerix, Inc.
CMRX
| $145K | ﹤0.01% |
+69,621
| New | +$224K |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.